期刊文献+

不同抗凝技术对CRRT滤器使用时间的观察 被引量:7

Observation of Using Time of CRRT Filters with Different Anticoagulant Techniques
下载PDF
导出
摘要 对用低分子肝素全身抗凝技术和枸橼酸局部抗凝技术行CRRT治疗的患者进行回顾性分析,比较不同抗凝技术对滤器使用时间的影响。将94例急性肾损伤危重患者按照不同的抗凝方案分为枸橼酸钠组和低分子肝素组,对2组患者的临床资料、活化部分凝血活酶时间(APTT)、凝血酶时间国际标准化比值(INR)、滤器使用时间、治疗效果和治疗过程中出血事件进行统计学比较。结果为2种不同抗凝方式对治疗效果无差异;低分子肝素抗凝的出血风险大于枸橼酸钠局部抗凝;枸橼酸钠局部抗凝技术对CRRT滤器的使用时间明显长于低分子肝素抗凝技术。枸橼酸局部抗凝技术在延长滤器使用时间、减少出血等方面有明显优势,可广泛应用于各种高出血风险的危重症患者CRRT的抗凝治疗。 Objective: To compare using time of filter with different anticoagulant techniques by a retrospective analysis of patients received CRRT treatment using low molecular weight heparin general anticoagulation or citrate regional antieoagulation. Methods: 94 critical patients with acute kidney injury were divided into anti- coagulant sodium citrate group and low molecular weight heparin group according to anticoagulant techniques they received. Clinical information, activated partial thromboplastin time (APTT), thrombin time, interna- tional normalized ratio ( INR), filter using time, treatment results and bleeding accidents during treatment were statistically eomparod. Results: There was no difference between treatment effects with the two different anticoagulant techniques. Bleeding risk with low molecular heparin general anticoagulation was higher than that with local sodium citrate local anticoagulation. Using time of CRRT filter with sodium citrate local anti-coagulation technique was longer than that with low-molecular weight heparin anticoagulant technique. Con- clusion: Sodium citrate local anticoagulation technique showed obvious advantages in prolonging using time of filter and reducing bleeding. The technique can be widely used in continuous renal replacement therapy (CRRT) anticoagulant therapy for critical patients with a variety of high bleeding risks.
出处 《湖北理工学院学报》 2013年第2期50-52,共3页 Journal of Hubei Polytechnic University
基金 湖北省黄石市医疗卫生科技攻关计划项目(项目编号:2011A045-4)
关键词 低分子肝素抗凝 枸橼酸抗凝 CRRT滤器 使用时间 low molecular weight heparin citrate anticoagulant CRRT filtem using time
  • 相关文献

参考文献4

二级参考文献10

共引文献14

同被引文献47

  • 1韦琳.ICU感染性休克病死危险因素及相应的临床治疗措施分析[J].今日健康,2016,15(4):109-109. 被引量:1
  • 2张萌.2种抗凝方法在CVVH中的应用比较与护理[J]中国实用护理杂志,2008,24(2):30-31.
  • 3Uchino S, Fealy N, BaldwinI, et al. Post-dilution during continuous veno-venoushemofiltration: impact on filter life and azotemic control[J]. Nephron Clin Pract,2003,94(4):94-98.
  • 4Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: theSeventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].Chest,Sep 2004,126(3): 188-203.
  • 5Bagshaw SM, Laupland KB, Boiteau PJ, et ahIs regional citrate superior to systemic heparin anticoagulatlon for continuous renalreplacement therapy A prospective observational study in an adult regional critical care system[J].J Crit Care,Jun 2005,20(2): 155-161.
  • 6Ronco C,Bellomo R. Acute renal failure and multiple or gan dysfunction in the ICU:from renal replacement thera- py (RRT) to multiple organ support therapy(MOST) [J]. Int J Artif Organs,2002,25(8) :733-747.
  • 7Ostermann M, Dickie H, Tovey L, et al. Heparin algo rithm for anticoagulation during continuous renal replace ment therapy[J]. Crit Care, 2010,14(3): 419-420.
  • 8陈小波,徐元钊,廖履坦.局部枸橼酸抗凝血液透析在高危出血患者中的应用[J].中华肾脏病杂志,1997,13(6):346-349. 被引量:32
  • 9王卓强,徐震,刘秀珍,范里莉.体外不同程度生理盐水稀释血液对凝血功能的影响[J].解放军医学杂志,2008,33(10):1268-1271. 被引量:6
  • 10阚蓉英,张学军,郑建华,陈兴娅.高危出血患者无肝素抗凝连续性肾替代治疗的护理[J].护理学杂志(综合版),2009,24(5):46-47. 被引量:22

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部